Partnering for Independence

Intercell AG knows that a top-tier, independent vaccines company eventually needs to have substantial sales and marketing muscle, but the company isn't ready to take on large scale commercialization in the near term. Instead, it is linking up with marketing partners in deals that allow it to retain a substantial chunk of profits that can be used to continue to build the company.

Having already established commercial ties with three big pharmas, Intercell is now tapping into the commercial skill of GlaxoSmithKline plc to advance a vaccine patch technology...